Published in Lancet on October 06, 2001
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis (2003) 2.85
Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension. Pulm Circ (2012) 0.95
A review of pulmonary arterial hypertension: role of ambrisentan. Vasc Health Risk Manag (2007) 0.90
Pulmonary hypertension associated with sickle cell disease: pathophysiology and rationale for treatment. Lung (2008) 0.84
Activation of ETB receptors regulates the abundance of ET-1 mRNA in vascular endothelial cells. Br J Pharmacol (2008) 0.83
Molecular imaging of the pulmonary circulation in health and disease. Clin Transl Imaging (2014) 0.79